Advertisement
Research Article

Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d'Ivoire

  • Armelle Pasquet mail,

    armellepasquet@hotmail.com

    Affiliation: Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Tourcoing, France

    X
  • Eugène Messou,

    Affiliation: Programme Aconda, Abidjan, Côte d'Ivoire

    X
  • Delphine Gabillard,

    Affiliation: INSERM U897, Bordeaux, France

    X
  • Albert Minga,

    Affiliations: INSERM U897, Bordeaux, France, Programme PACCI, Abidjan, Côte d'Ivoire

    X
  • Ayeby Depoulosky,

    Affiliation: Programme Aconda, Abidjan, Côte d'Ivoire

    X
  • Sylvie Deuffic-Burban,

    Affiliations: INSERM U995, Lille, France, EA 2694, Faculté de Médecine de Lille, France

    X
  • Elena Losina,

    Affiliation: Massachusetts General Hospital, Boston, Massachusetts, United States of America

    X
  • Kenneth A. Freedberg,

    Affiliation: Massachusetts General Hospital, Boston, Massachusetts, United States of America

    X
  • Christine Danel,

    Affiliations: INSERM U897, Bordeaux, France, Programme PACCI, Abidjan, Côte d'Ivoire

    X
  • Xavier Anglaret,

    Affiliations: INSERM U897, Bordeaux, France, Programme PACCI, Abidjan, Côte d'Ivoire

    X
  • Yazdan Yazdanpanah

    Affiliations: Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Tourcoing, France, EA 2694, Faculté de Médecine de Lille, France

    X
  • Published: October 15, 2010
  • DOI: 10.1371/journal.pone.0013414

About the Authors

Armelle Pasquet, Yazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Tourcoing, France
Eugène Messou, Ayeby Depoulosky
Programme Aconda, Abidjan, Côte d'Ivoire
Delphine Gabillard, Albert Minga, Christine Danel, Xavier Anglaret
INSERM U897, Bordeaux, France
Albert Minga, Christine Danel, Xavier Anglaret
Programme PACCI, Abidjan, Côte d'Ivoire
Sylvie Deuffic-Burban
INSERM U995, Lille, France
Sylvie Deuffic-Burban, Yazdan Yazdanpanah
EA 2694, Faculté de Médecine de Lille, France
Elena Losina, Kenneth A. Freedberg
Massachusetts General Hospital, Boston, Massachusetts, United States of America

Corresponding Author

Email: armellepasquet@hotmail.com

Competing Interests

With the exception of Yazdan Yazdanpanah and Sylvie Deuffic-Burban none of the authors report any association that might pose a conflict of interest. Dr. Yazdanpanah has received travel grants, consultancy fees and honoraria for presentation at workshops from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Glaxo-SmithKline, Merck-Sharp and Dohme-Chibret, Pfizer, Roche, Schering Plough and Tibotec. Mrs. Deuffic-Burban has received grants from Roche and Janssen-Cilag. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: AP EM DG SDB EL KAF CD XA YY. Performed the experiments: AP EM AM AD CD. Analyzed the data: AP DG SDB. Contributed reagents/materials/analysis tools: AP EM AM AD EL KAF CD XA YY. Wrote the paper: AP YY.